查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球細胞應變市場（2022 年）
市場調查報告書
商品編碼
1080303

全球細胞應變市場（2022 年）

Global Cell Line Generation Market Research Report 2022
出版日期: | 出版商: QYResearch | 英文 104 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球細胞系生產市場預計將從 2021 年的 16.784 億美元增長到 2028 年的 31.845 億美元。

預計在 2022 年至 2028 年期間，其複合年增長率將達到 9.95%。

按類型劃分，敲除細胞系預計將在 2021 年佔全球市場的 49.39%，並在 COVID-19 之後的時期以 22.55% 的複合年增長率增長。通過應用，製藥行業預計在預測期內以 10.19% 的複合年增長率增長。

按地區劃分，2021 年北美市場份額為 33.41%，中國市場份額為 6.08%，歐洲市場份額為 36.89%。

本報告分析了全球細胞系生產市場，並按類型、用途和地區（國家）（2017-2028）、主要公司概況等調查了市場趨勢的前景。

內容

第一章調查概要

  • 調查範圍
  • 按類型劃分的市場分析
    • 市場規模/增長率：按類型（2017、2021、2028）
    • 基因敲除細胞系
    • 過表達細胞系
    • 誘導表達細胞系
    • 敲低細胞系
    • 敲入細胞系
    • 其他
  • 按應用進行營銷
    • 市場份額：按應用分類（2017、2021、2028）
    • 醫藥行業
    • 生物產業
  • 分析目標
  • 分析期

第二章全球增長趨勢

  • 全球細胞系生產市場展望（2017-2028）
  • 細胞系創建的增長趨勢：按地區劃分
  • 細胞系創建的市場動態

第三章主要公司的競爭情況

  • 主要細胞系創造者的利潤
  • 市場份額：按公司類型（1 級、2 級、3 級）
  • 待分析公司：細胞系創建利潤排名
  • 全球細胞系生產市場集中度
  • 生產細胞系的主要公司：總部/服務區
  • 領先的細胞系創建公司：產品、解決方案、服務
  • 細胞系創建者成立時間

第 4 章細胞系創建：按類型細分數據

  • 過去的市場規模：按類型（2017-2022）
  • 市場規模預測：按類型（2023-2028 年）

第 5 章細胞系創建：按應用細分數據

  • 過去的市場規模：按應用（2017-2022）
  • 市場規模預測：按應用分類（2023-2028）

第 6 章北美

  • 北美細胞系生產市場規模（2017-2028）
  • 細胞系生產市場規模：按國家分類（2017-2022）
  • 細胞系生產市場規模：按國家分類（2023-2028）
  • 美國
  • 加拿大

第7章歐洲

  • 歐洲細胞系生產市場規模（2017-2028）
  • 細胞系生產市場規模：按國家分類（2017-2022）
  • 細胞系生產市場規模：按國家分類（2023-2028）
  • 德國
  • 法國
  • 英國
  • 意大利
  • 俄羅斯
  • 斯堪的納維亞國家

第 8 章亞太區

  • 亞太細胞系生產市場規模（2017-2028）
  • 細胞系生產市場規模：分地區（2017-2022）
  • 細胞系生產市場規模：按地區劃分（2023-2028）
  • 中國
  • 日本
  • 韓國
  • 東南亞
  • 印度
  • 澳大利亞

第9章拉丁美洲

  • 拉丁美洲細胞系生產市場規模（2017-2028）
  • 細胞系生產市場規模：按國家分類（2017-2022）
  • 細胞系生產市場規模：按國家分類（2023-2028）
  • 墨西哥
  • 巴西

第10章中東/非洲

  • 中東和非洲細胞系生產市場規模（2017-2028）
  • 細胞系生產市場規模：按國家分類（2017-2022）
  • 細胞系生產市場規模：按國家分類（2023-2028）
  • 土耳其
  • 沙特阿拉伯
  • 阿拉伯聯合酋長國

第11章主要公司簡介

  • BOEHRINGER INGELHEIM BIOXCELLENCE
  • LONZA GROUP AG
  • WUXI BIOLOGICS
  • THERMO FISHER SCIENTIFIC
  • SARTORIOUS AG
  • MERCK KGAA
  • CATALENT
  • SAMSUNG BIOLOGICS
  • FUJIFILM DIOSYNTH BIOTECHNOLOGIES
  • PORTON BIOLOGICS
  • CHEMPARTNER PHARMATECH
  • RENTSCHLER BIOPHARMA
  • PROBIOGEN
  • AGC BIOLOGICS
  • OPM BIOSCIENCES
  • CHARLES RIVER LABORATORIES
  • MYCENAX BIOTECH
  • JOINN LAB

第 12 章分析師的觀點/結論

第13章附錄

Market Analysis and Insights: Global Cell Line Generation Market

The global Cell Line Generation market size is projected to reach US$ 3,184.5 million by 2028, from US$ 1,678.4 million in 2021, at a CAGR of 9.95% during 2022-2028.

Fully considering the economic change by this health crisis, Knockout Cell Lines accounting for 49.39% of the Cell Line Generation global market in 2021, is projected to value US$ 1,711.7 million by 2028, growing at a revised 22.55% CAGR in the post-COVID-19 period. While Pharmaceutical Industry segment is altered to an 10.19% CAGR throughout this forecast period.

China Cell Line Generation market size is valued at US$ 102.1 million in 2021, while the North America and Europe Cell Line Generation are US$ 560.7 million and US$ 619.1 million, severally. The proportion of the North America is 33.41% in 2021, while China and Europe are 6.08% and 36.89% respectively, and it is predicted that China proportion will reach 11.30% in 2028, trailing a CAGR of 21.48% through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR 12.32%, 8.46%, and 8.52% respectively for the next 6-year period. As for the Europe Cell Line Generation landscape, Germany is projected to reach US$ 234.7 million by 2028 trailing a CAGR of 7.89% over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Line Generation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Line Generation market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Line Generation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Line Generation market.

Global Cell Line Generation Scope and Market Size

Cell Line Generation market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell Line Generation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company

Boehringer Ingelheim BioXcellence

Lonza

WuXi Biologics

Thermo Fisher Scientific

Sartorius

Merck

Catalent

Samsung Biologics

FUJIFILM Diosynth Biotechnologies

Porton Biologics

Chempartner Pharmatech

Rentschler Biopharma

ProBioGen

AGC Biologics

OPM Biosciences

Charles River Laboratories

Mycenax Biotech

JOINN Laboratories

Segment by Type

Knockout Cell Lines

Overexpression Cell Lines

Inducible Expression Cell Lines

Knockdown Cell Lines

Knockin Cell Lines

Others

Segment by Application

Pharmaceutical Industry

Biological Industry

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

South America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

TABLE OF CONTENTS

TABLE OF CONTENTS

1 REPORT OVERVIEW 1

  • 1.1 STUDY SCOPE 1
  • 1.2 MARKET ANALYSIS BY TYPE 1
    • 1.2.1 GLOBAL CELL LINE GENERATION MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028 1
    • 1.2.2 KNOCKOUT CELL LINES 2
    • 1.2.3 OVEREXPRESSION CELL LINES 2
    • 1.2.4 INDUCIBLE EXPRESSION CELL LINES 3
    • 1.2.5 KNOCKDOWN CELL LINES 3
    • 1.2.6 KNOCKIN CELL LINES 3
    • 1.2.7 OTHERS 4
  • 1.3 MARKET BY APPLICATION 4
    • 1.3.1 GLOBAL CELL LINE GENERATION MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028 4
    • 1.3.2 PHARMACEUTICAL INDUSTRY 5
    • 1.3.3 BIOLOGICAL INDUSTRY 5
  • 1.4 STUDY OBJECTIVES 5
  • 1.5 YEARS CONSIDERED 6

2 GLOBAL GROWTH TRENDS 7

  • 2.1 GLOBAL CELL LINE GENERATION MARKET PERSPECTIVE (2017-2028) 7
  • 2.2 CELL LINE GENERATION GROWTH TRENDS BY REGION 8
    • 2.2.1 CELL LINE GENERATION MARKET SIZE BY REGION: 2017 VS 2021 VS 2028 8
    • 2.2.2 CELL LINE GENERATION HISTORIC MARKET SIZE BY REGION (2017-2022) 9
    • 2.2.3 CELL LINE GENERATION FORECASTED MARKET SIZE BY REGION (2023-2028) 10
  • 2.3 CELL LINE GENERATION MARKET DYNAMICS 10
    • 2.3.1 CELL LINE GENERATION INDUSTRY TRENDS 10
    • 2.3.2 CELL LINE GENERATION MARKET DRIVERS 11
    • 2.3.3 CELL LINE GENERATION MARKET CHALLENGES 11
    • 2.3.4 CELL LINE GENERATION MARKET RESTRAINTS 12

3 COMPETITION LANDSCAPE BY KEY PLAYERS 13

  • 3.1 GLOBAL TOP CELL LINE GENERATION PLAYERS BY REVENUE 13
    • 3.1.1 GLOBAL TOP CELL LINE GENERATION PLAYERS BY REVENUE (2017-2022) 13
    • 3.1.2 GLOBAL CELL LINE GENERATION REVENUE MARKET SHARE BY PLAYERS (2017-2022) 14
  • 3.2 GLOBAL CELL LINE GENERATION MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 15
  • 3.3 PLAYERS COVERED: RANKING BY CELL LINE GENERATION REVENUE 16
  • 3.4 GLOBAL CELL LINE GENERATION MARKET CONCENTRATION RATIO 17
    • 3.4.1 GLOBAL CELL LINE GENERATION MARKET CONCENTRATION RATIO (CR5) 17
  • 3.5 CELL LINE GENERATION KEY PLAYERS HEAD OFFICE AND AREA SERVED 18
  • 3.6 KEY PLAYERS CELL LINE GENERATION PRODUCT SOLUTION AND SERVICE 18
  • 3.7 ESTABLISHED DATE CELL LINE GENERATION MANUFACTURER 19

4 CELL LINE GENERATION BREAKDOWN DATA BY TYPE 21

  • 4.1 GLOBAL CELL LINE GENERATION HISTORIC MARKET SIZE BY TYPE (2017-2022) 21
  • 4.2 GLOBAL CELL LINE GENERATION FORECASTED MARKET SIZE BY TYPE (2023-2028) 22

5 CELL LINE GENERATION BREAKDOWN DATA BY APPLICATION 23

  • 5.1 GLOBAL CELL LINE GENERATION HISTORIC MARKET SIZE BY APPLICATION (2017-2022) 23
  • 5.2 GLOBAL CELL LINE GENERATION FORECASTED MARKET SIZE BY APPLICATION (2023-2028) 23

6 NORTH AMERICA 25

  • 6.1 NORTH AMERICA CELL LINE GENERATION MARKET SIZE (2017-2028) 25
  • 6.2 NORTH AMERICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2017-2022) 25
  • 6.3 NORTH AMERICA CELL LINE GENERATION MARKET SHARE BY COUNTRY (2023-2028) 26
  • 6.4 UNITED STATES 27
  • 6.5 CANADA 27

7 EUROPE 28

  • 7.1 EUROPE CELL LINE GENERATION MARKET SIZE (2017-2028) 28
  • 7.2 EUROPE CELL LINE GENERATION MARKET SIZE BY COUNTRY (2017-2022) 28
  • 7.3 EUROPE CELL LINE GENERATION MARKET SIZE BY COUNTRY (2023-2028) 29
  • 7.4 GERMANY 30
  • 7.5 FRANCE 30
  • 7.6 U.K. 31
  • 7.7 ITALY 31
  • 7.8 RUSSIA 32
  • 7.9 NORDIC COUNTRIES 32

8 ASIA-PACIFIC 33

  • 8.1 ASIA-PACIFIC CELL LINE GENERATION MARKET SIZE (2017-2028) 33
  • 8.2 ASIA-PACIFIC CELL LINE GENERATION MARKET SIZE BY REGION (2017-2022) 33
  • 8.3 ASIA-PACIFIC CELL LINE GENERATION MARKET SIZE BY REGION (2023-2028) 34
  • 8.4 CHINA 35
  • 8.5 JAPAN 35
  • 8.6 SOUTH KOREA 36
  • 8.7 SOUTHEAST ASIA 36
  • 8.8 INDIA 37
  • 8.9 AUSTRALIA 37

9 LATIN AMERICA 38

  • 9.1 LATIN AMERICA CELL LINE GENERATION MARKET SIZE (2017-2028) 38
  • 9.2 LATIN AMERICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2017-2022) 38
  • 9.3 LATIN AMERICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2023-2028) 39
  • 9.4 MEXICO 40
  • 9.5 BRAZIL 40

10 MIDDLE EAST & AFRICA 41

  • 10.1 MIDDLE EAST & AFRICA CELL LINE GENERATION MARKET SIZE (2017-2028) 41
  • 10.2 MIDDLE EAST & AFRICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2017-2022) 41
  • 10.3 MIDDLE EAST & AFRICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2023-2028) 42
  • 10.4 TURKEY 43
  • 10.5 SAUDI ARABIA 43
  • 10.6 UAE 44

11 KEY PLAYERS PROFILES 45

  • 11.1 BOEHRINGER INGELHEIM BIOXCELLENCE 45
    • 11.1.1 BOEHRINGER INGELHEIM BIOXCELLENCE COMPANY DETAILS 45
    • 11.1.2 BOEHRINGER INGELHEIM BIOXCELLENCE BUSINESS OVERVIEW 45
    • 11.1.3 BOEHRINGER INGELHEIM BIOXCELLENCE CELL LINE GENERATION INTRODUCTION 46
    • 11.1.4 BOEHRINGER INGELHEIM BIOXCELLENCE REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 47
  • 11.2 LONZA GROUP AG 47
    • 11.2.1 LONZA GROUP AG COMPANY DETAILS 47
    • 11.2.2 LONZA GROUP AG BUSINESS OVERVIEW 47
    • 11.2.3 LONZA GROUP AG CELL LINE GENERATION INTRODUCTION 48
    • 11.2.4 LONZA GROUP AG REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 49
  • 11.3 WUXI BIOLOGICS 49
    • 11.3.1 WUXI BIOLOGICS COMPANY DETAILS 49
    • 11.3.2 WUXI BIOLOGICS BUSINESS OVERVIEW 49
    • 11.3.3 WUXI BIOLOGICS CELL LINE GENERATION INTRODUCTION 50
    • 11.3.4 WUXI BIOLOGICS REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 50
    • 11.3.5 WUXI BIOLOGICS RECENT DEVELOPMENT 50
  • 11.4 THERMO FISHER SCIENTIFIC 51
    • 11.4.1 THERMO FISHER SCIENTIFIC COMPANY DETAILS 51
    • 11.4.2 THERMO FISHER SCIENTIFIC BUSINESS OVERVIEW 51
    • 11.4.3 THERMO FISHER SCIENTIFIC CELL LINE GENERATION INTRODUCTION 52
    • 11.4.4 THERMO FISHER SCIENTIFIC REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 52
  • 11.5 SARTORIOUS AG 53
    • 11.5.1 SARTORIOUS AG COMPANY DETAILS 53
    • 11.5.2 SARTORIOUS AG BUSINESS OVERVIEW 53
    • 11.5.3 SARTORIOUS AG CELL LINE GENERATION INTRODUCTION 54
    • 11.5.4 SARTORIOUS AG REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 54
    • 11.5.5 SARTORIOUS AG RECENT DEVELOPMENT 54
  • 11.6 MERCK KGAA 55
    • 11.6.1 MERCK KGAA COMPANY DETAILS 55
    • 11.6.2 MERCK KGAA BUSINESS OVERVIEW 55
    • 11.6.3 MERCK KGAA CELL LINE GENERATION INTRODUCTION 56
    • 11.6.4 MERCK KGAA REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 56
    • 11.6.5 MERCK KGAA RECENT DEVELOPMENT 56
  • 11.7 CATALENT 57
    • 11.7.1 CATALENT COMPANY DETAILS 57
    • 11.7.2 CATALENT BUSINESS OVERVIEW 57
    • 11.7.3 CATALENT CELL LINE GENERATION INTRODUCTION 58
    • 11.7.4 CATALENT REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 58
  • 11.8 SAMSUNG BIOLOGICS 59
    • 11.8.1 SAMSUNG BIOLOGICS COMPANY DETAILS 59
    • 11.8.2 SAMSUNG BIOLOGICS BUSINESS OVERVIEW 59
    • 11.8.3 SAMSUNG BIOLOGICS CELL LINE GENERATION INTRODUCTION 60
    • 11.8.4 SAMSUNG BIOLOGICS REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 60
  • 11.9 FUJIFILM DIOSYNTH BIOTECHNOLOGIES 60
    • 11.9.1 FUJIFILM DIOSYNTH BIOTECHNOLOGIES COMPANY DETAILS 60
    • 11.9.2 FUJIFILM DIOSYNTH BIOTECHNOLOGIES BUSINESS OVERVIEW 61
    • 11.9.3 FUJIFILM DIOSYNTH BIOTECHNOLOGIES CELL LINE GENERATION INTRODUCTION 61
    • 11.9.4 FUJIFILM DIOSYNTH BIOTECHNOLOGIES REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 62
  • 11.10 PORTON BIOLOGICS 62
    • 11.10.1 PORTON BIOLOGICS COMPANY DETAILS 62
    • 11.10.2 PORTON BIOLOGICS BUSINESS OVERVIEW 62
    • 11.10.3 PORTON BIOLOGICS CELL LINE GENERATION INTRODUCTION 63
    • 11.10.4 PORTON BIOLOGICS REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 63
  • 11.11 CHEMPARTNER PHARMATECH 64
    • 11.11.1 CHEMPARTNER PHARMATECH COMPANY DETAILS 64
    • 11.11.2 CHEMPARTNER PHARMATECH BUSINESS OVERVIEW 64
    • 11.11.3 CHEMPARTNER PHARMATECH CELL LINE GENERATION INTRODUCTION 65
    • 11.11.4 CHEMPARTNER PHARMATECH REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 65
  • 11.12 RENTSCHLER BIOPHARMA 65
    • 11.12.1 RENTSCHLER BIOPHARMA COMPANY DETAILS 65
    • 11.12.2 RENTSCHLER BIOPHARMA BUSINESS OVERVIEW 66
    • 11.12.3 RENTSCHLER BIOPHARMA CELL LINE GENERATION INTRODUCTION 66
    • 11.12.4 RENTSCHLER BIOPHARMA REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 67
  • 11.13 PROBIOGEN 67
    • 11.13.1 PROBIOGEN COMPANY DETAILS 67
    • 11.13.2 PROBIOGEN BUSINESS OVERVIEW 68
    • 11.13.3 PROBIOGEN CELL LINE GENERATION INTRODUCTION 68
    • 11.13.4 PROBIOGEN REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 68
  • 11.14 AGC BIOLOGICS 69
    • 11.14.1 AGC BIOLOGICS COMPANY DETAILS 69
    • 11.14.2 AGC BIOLOGICS BUSINESS OVERVIEW 69
    • 11.14.3 AGC BIOLOGICS CELL LINE GENERATION INTRODUCTION 70
    • 11.14.4 AGC BIOLOGICS REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 70
  • 11.15 OPM BIOSCIENCES 70
    • 11.15.1 OPM BIOSCIENCES COMPANY DETAILS 71
    • 11.15.2 OPM BIOSCIENCES BUSINESS OVERVIEW 71
    • 11.15.3 OPM BIOSCIENCES CELL LINE GENERATION INTRODUCTION 71
    • 11.15.4 OPM BIOSCIENCES REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 72
  • 11.16 CHARLES RIVER LABORATORIES 72
    • 11.16.1 CHARLES RIVER LABORATORIES COMPANY DETAILS 72
    • 11.16.2 CHARLES RIVER LABORATORIES BUSINESS OVERVIEW 73
    • 11.16.3 CHARLES RIVER LABORATORIES CELL LINE GENERATION INTRODUCTION 73
    • 11.16.4 CHARLES RIVER LABORATORIES REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 74
  • 11.17 MYCENAX BIOTECH 74
    • 11.17.1 MYCENAX BIOTECH COMPANY DETAILS 74
    • 11.17.2 MYCENAX BIOTECH BUSINESS OVERVIEW 75
    • 11.17.3 MYCENAX BIOTECH CELL LINE GENERATION INTRODUCTION 75
    • 11.17.4 MYCENAX BIOTECH REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 76
  • 11.18 JOINN LAB 76
    • 11.18.1 JOINN LAB COMPANY DETAILS 76
    • 11.18.2 JOINN LAB BUSINESS OVERVIEW 77
    • 11.18.3 JOINN LAB CELL LINE GENERATION INTRODUCTION 77
    • 11.18.4 JOINN LAB REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022) 78

12 ANALYST'S VIEWPOINTS/CONCLUSIONS 79

13 APPENDIX 80

  • 13.1 RESEARCH METHODOLOGY 80
    • 13.1.1 METHODOLOGY/RESEARCH APPROACH 80
    • 13.1.2 DATA SOURCE 83
  • 13.2 DISCLAIMER 86
  • 13.3 AUTHOR DETAILS 86

LIST OF TABLES

1 REPORT OVERVIEW

  • 1.1 STUDY SCOPE
  • 1.2 MARKET ANALYSIS BY TYPE
    • 1.2.1 GLOBAL CELL LINE GENERATION MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028
    • 1.2.2 KNOCKOUT CELL LINES
    • 1.2.3 OVEREXPRESSION CELL LINES
    • 1.2.4 INDUCIBLE EXPRESSION CELL LINES
    • 1.2.5 KNOCKDOWN CELL LINES
    • 1.2.6 KNOCKIN CELL LINES
    • 1.2.7 OTHERS
  • 1.3 MARKET BY APPLICATION
    • 1.3.1 GLOBAL CELL LINE GENERATION MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028
    • 1.3.2 PHARMACEUTICAL INDUSTRY
    • 1.3.3 BIOLOGICAL INDUSTRY
  • 1.4 STUDY OBJECTIVES
  • 1.5 YEARS CONSIDERED

2 GLOBAL GROWTH TRENDS

  • 2.1 GLOBAL CELL LINE GENERATION MARKET PERSPECTIVE (2017-2028)
  • 2.2 CELL LINE GENERATION GROWTH TRENDS BY REGION
    • 2.2.1 CELL LINE GENERATION MARKET SIZE BY REGION: 2017 VS 2021 VS 2028
    • 2.2.2 CELL LINE GENERATION HISTORIC MARKET SIZE BY REGION (2017-2022)
    • 2.2.3 CELL LINE GENERATION FORECASTED MARKET SIZE BY REGION (2023-2028)
  • 2.3 CELL LINE GENERATION MARKET DYNAMICS
    • 2.3.1 CELL LINE GENERATION INDUSTRY TRENDS
    • 2.3.2 CELL LINE GENERATION MARKET DRIVERS
    • 2.3.3 CELL LINE GENERATION MARKET CHALLENGES
    • 2.3.4 CELL LINE GENERATION MARKET RESTRAINTS

3 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 3.1 GLOBAL TOP CELL LINE GENERATION PLAYERS BY REVENUE
    • 3.1.1 GLOBAL TOP CELL LINE GENERATION PLAYERS BY REVENUE (2017-2022)
    • 3.1.2 GLOBAL CELL LINE GENERATION REVENUE MARKET SHARE BY PLAYERS (2017-2022)
  • 3.2 GLOBAL CELL LINE GENERATION MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)
  • 3.3 PLAYERS COVERED: RANKING BY CELL LINE GENERATION REVENUE
  • 3.4 GLOBAL CELL LINE GENERATION MARKET CONCENTRATION RATIO
    • 3.4.1 GLOBAL CELL LINE GENERATION MARKET CONCENTRATION RATIO (CR5)
  • 3.5 CELL LINE GENERATION KEY PLAYERS HEAD OFFICE AND AREA SERVED
  • 3.6 KEY PLAYERS CELL LINE GENERATION PRODUCT SOLUTION AND SERVICE
  • 3.7 ESTABLISHED DATE CELL LINE GENERATION MANUFACTURER

4 CELL LINE GENERATION BREAKDOWN DATA BY TYPE

  • 4.1 GLOBAL CELL LINE GENERATION HISTORIC MARKET SIZE BY TYPE (2017-2022)
  • 4.2 GLOBAL CELL LINE GENERATION FORECASTED MARKET SIZE BY TYPE (2023-2028)

5 CELL LINE GENERATION BREAKDOWN DATA BY APPLICATION

  • 5.1 GLOBAL CELL LINE GENERATION HISTORIC MARKET SIZE BY APPLICATION (2017-2022)
  • 5.2 GLOBAL CELL LINE GENERATION FORECASTED MARKET SIZE BY APPLICATION (2023-2028)

6 NORTH AMERICA

  • 6.1 NORTH AMERICA CELL LINE GENERATION MARKET SIZE (2017-2028)
  • 6.2 NORTH AMERICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2017-2022)
  • 6.3 NORTH AMERICA CELL LINE GENERATION MARKET SHARE BY COUNTRY (2023-2028)
  • 6.4 UNITED STATES
  • 6.5 CANADA

7 EUROPE

  • 7.1 EUROPE CELL LINE GENERATION MARKET SIZE (2017-2028)
  • 7.2 EUROPE CELL LINE GENERATION MARKET SIZE BY COUNTRY (2017-2022)
  • 7.3 EUROPE CELL LINE GENERATION MARKET SIZE BY COUNTRY (2023-2028)
  • 7.4 GERMANY
  • 7.5 FRANCE
  • 7.6 U.K.
  • 7.7 ITALY
  • 7.8 RUSSIA
  • 7.9 NORDIC COUNTRIES

8 ASIA-PACIFIC

  • 8.1 ASIA-PACIFIC CELL LINE GENERATION MARKET SIZE (2017-2028)
  • 8.2 ASIA-PACIFIC CELL LINE GENERATION MARKET SIZE BY REGION (2017-2022)
  • 8.3 ASIA-PACIFIC CELL LINE GENERATION MARKET SIZE BY REGION (2023-2028)
  • 8.4 CHINA
  • 8.5 JAPAN
  • 8.6 SOUTH KOREA
  • 8.7 SOUTHEAST ASIA
  • 8.8 INDIA
  • 8.9 AUSTRALIA

9 LATIN AMERICA

  • 9.1 LATIN AMERICA CELL LINE GENERATION MARKET SIZE (2017-2028)
  • 9.2 LATIN AMERICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2017-2022)
  • 9.3 LATIN AMERICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2023-2028)
  • 9.4 MEXICO
  • 9.5 BRAZIL

10 MIDDLE EAST & AFRICA

  • 10.1 MIDDLE EAST & AFRICA CELL LINE GENERATION MARKET SIZE (2017-2028)
  • 10.2 MIDDLE EAST & AFRICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2017-2022)
  • 10.3 MIDDLE EAST & AFRICA CELL LINE GENERATION MARKET SIZE BY COUNTRY (2023-2028)
  • 10.4 TURKEY
  • 10.5 SAUDI ARABIA
  • 10.6 UAE

11 KEY PLAYERS PROFILES

  • 11.1 BOEHRINGER INGELHEIM BIOXCELLENCE
    • 11.1.1 BOEHRINGER INGELHEIM BIOXCELLENCE COMPANY DETAILS
    • 11.1.2 BOEHRINGER INGELHEIM BIOXCELLENCE BUSINESS OVERVIEW
    • 11.1.3 BOEHRINGER INGELHEIM BIOXCELLENCE CELL LINE GENERATION INTRODUCTION
    • 11.1.4 BOEHRINGER INGELHEIM BIOXCELLENCE REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.2 LONZA GROUP AG
    • 11.2.1 LONZA GROUP AG COMPANY DETAILS
    • 11.2.2 LONZA GROUP AG BUSINESS OVERVIEW
    • 11.2.3 LONZA GROUP AG CELL LINE GENERATION INTRODUCTION
    • 11.2.4 LONZA GROUP AG REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.3 WUXI BIOLOGICS
    • 11.3.1 WUXI BIOLOGICS COMPANY DETAILS
    • 11.3.2 WUXI BIOLOGICS BUSINESS OVERVIEW
    • 11.3.3 WUXI BIOLOGICS CELL LINE GENERATION INTRODUCTION
    • 11.3.4 WUXI BIOLOGICS REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
    • 11.3.5 WUXI BIOLOGICS RECENT DEVELOPMENT
  • 11.4 THERMO FISHER SCIENTIFIC
    • 11.4.1 THERMO FISHER SCIENTIFIC COMPANY DETAILS
    • 11.4.2 THERMO FISHER SCIENTIFIC BUSINESS OVERVIEW
    • 11.4.3 THERMO FISHER SCIENTIFIC CELL LINE GENERATION INTRODUCTION
    • 11.4.4 THERMO FISHER SCIENTIFIC REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.5 SARTORIOUS AG
    • 11.5.1 SARTORIOUS AG COMPANY DETAILS
    • 11.5.2 SARTORIOUS AG BUSINESS OVERVIEW
    • 11.5.3 SARTORIOUS AG CELL LINE GENERATION INTRODUCTION
    • 11.5.4 SARTORIOUS AG REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
    • 11.5.5 SARTORIOUS AG RECENT DEVELOPMENT
  • 11.6 MERCK KGAA
    • 11.6.1 MERCK KGAA COMPANY DETAILS
    • 11.6.2 MERCK KGAA BUSINESS OVERVIEW
    • 11.6.3 MERCK KGAA CELL LINE GENERATION INTRODUCTION
    • 11.6.4 MERCK KGAA REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
    • 11.6.5 MERCK KGAA RECENT DEVELOPMENT
  • 11.7 CATALENT
    • 11.7.1 CATALENT COMPANY DETAILS
    • 11.7.2 CATALENT BUSINESS OVERVIEW
    • 11.7.3 CATALENT CELL LINE GENERATION INTRODUCTION
    • 11.7.4 CATALENT REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.8 SAMSUNG BIOLOGICS
    • 11.8.1 SAMSUNG BIOLOGICS COMPANY DETAILS
    • 11.8.2 SAMSUNG BIOLOGICS BUSINESS OVERVIEW
    • 11.8.3 SAMSUNG BIOLOGICS CELL LINE GENERATION INTRODUCTION
    • 11.8.4 SAMSUNG BIOLOGICS REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.9 FUJIFILM DIOSYNTH BIOTECHNOLOGIES
    • 11.9.1 FUJIFILM DIOSYNTH BIOTECHNOLOGIES COMPANY DETAILS
    • 11.9.2 FUJIFILM DIOSYNTH BIOTECHNOLOGIES BUSINESS OVERVIEW
    • 11.9.3 FUJIFILM DIOSYNTH BIOTECHNOLOGIES CELL LINE GENERATION INTRODUCTION
    • 11.9.4 FUJIFILM DIOSYNTH BIOTECHNOLOGIES REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.10 PORTON BIOLOGICS
    • 11.10.1 PORTON BIOLOGICS COMPANY DETAILS
    • 11.10.2 PORTON BIOLOGICS BUSINESS OVERVIEW
    • 11.10.3 PORTON BIOLOGICS CELL LINE GENERATION INTRODUCTION
    • 11.10.4 PORTON BIOLOGICS REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.11 CHEMPARTNER PHARMATECH
    • 11.11.1 CHEMPARTNER PHARMATECH COMPANY DETAILS
    • 11.11.2 CHEMPARTNER PHARMATECH BUSINESS OVERVIEW
    • 11.11.3 CHEMPARTNER PHARMATECH CELL LINE GENERATION INTRODUCTION
    • 11.11.4 CHEMPARTNER PHARMATECH REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.12 RENTSCHLER BIOPHARMA
    • 11.12.1 RENTSCHLER BIOPHARMA COMPANY DETAILS
    • 11.12.2 RENTSCHLER BIOPHARMA BUSINESS OVERVIEW
    • 11.12.3 RENTSCHLER BIOPHARMA CELL LINE GENERATION INTRODUCTION
    • 11.12.4 RENTSCHLER BIOPHARMA REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.13 PROBIOGEN
    • 11.13.1 PROBIOGEN COMPANY DETAILS
    • 11.13.2 PROBIOGEN BUSINESS OVERVIEW
    • 11.13.3 PROBIOGEN CELL LINE GENERATION INTRODUCTION
    • 11.13.4 PROBIOGEN REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.14 AGC BIOLOGICS
    • 11.14.1 AGC BIOLOGICS COMPANY DETAILS
    • 11.14.2 AGC BIOLOGICS BUSINESS OVERVIEW
    • 11.14.3 AGC BIOLOGICS CELL LINE GENERATION INTRODUCTION
    • 11.14.4 AGC BIOLOGICS REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.15 OPM BIOSCIENCES
    • 11.15.1 OPM BIOSCIENCES COMPANY DETAILS
    • 11.15.2 OPM BIOSCIENCES BUSINESS OVERVIEW
    • 11.15.3 OPM BIOSCIENCES CELL LINE GENERATION INTRODUCTION
    • 11.15.4 OPM BIOSCIENCES REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.16 CHARLES RIVER LABORATORIES
    • 11.16.1 CHARLES RIVER LABORATORIES COMPANY DETAILS
    • 11.16.2 CHARLES RIVER LABORATORIES BUSINESS OVERVIEW
    • 11.16.3 CHARLES RIVER LABORATORIES CELL LINE GENERATION INTRODUCTION
    • 11.16.4 CHARLES RIVER LABORATORIES REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.17 MYCENAX BIOTECH
    • 11.17.1 MYCENAX BIOTECH COMPANY DETAILS
    • 11.17.2 MYCENAX BIOTECH BUSINESS OVERVIEW
    • 11.17.3 MYCENAX BIOTECH CELL LINE GENERATION INTRODUCTION
    • 11.17.4 MYCENAX BIOTECH REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)
  • 11.18 JOINN LAB
    • 11.18.1 JOINN LAB COMPANY DETAILS
    • 11.18.2 JOINN LAB BUSINESS OVERVIEW
    • 11.18.3 JOINN LAB CELL LINE GENERATION INTRODUCTION
    • 11.18.4 JOINN LAB REVENUE IN CELL LINE GENERATION BUSINESS (2017-2022)

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

  • 13.1 RESEARCH METHODOLOGY
    • 13.1.1 METHODOLOGY/RESEARCH APPROACH
    • 13.1.2 DATA SOURCE
  • 13.2 DISCLAIMER
  • 13.3 AUTHOR DETAILS

List of Tables

  • Table 1. Global Cell Line Generation Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
  • Table 2. Key Players of Knockout Cell Lines
  • Table 3. Key Players of Overexpression Cell Lines
  • Table 4. Key Players of Inducible Expression Cell Lines
  • Table 5. Key Players of Knockdown Cell Lines
  • Table 6. Key Players of Knockin Cell Lines
  • Table 7. Global Cell Line Generation Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Cell Line Generation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 9. Global Cell Line Generation Market Size by Region (2017-2022) & (US$ Million)
  • Table 10. Global Cell Line Generation Market Share by Region (2017-2022)
  • Table 11. Global Cell Line Generation Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 12. Global Cell Line Generation Market Share by Region (2023-2028)
  • Table 13. Cell Line Generation Market Trends
  • Table 14. Cell Line Generation Market Drivers
  • Table 15. Cell Line Generation Market Challenges
  • Table 16. Cell Line Generation Market Restraints
  • Table 17. Global Cell Line Generation Revenue by Players (2017-2022) & (US$ Million)
  • Table 18. Global Cell Line Generation Market Share by Players (2017-2022)
  • Table 19. Global Top Cell Line Generation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Line Generation as of 2021)
  • Table 20. Ranking of Global Top Cell Line Generation Companies by Revenue (US$ Million) in 2021
  • Table 21. Global 5 Largest Players Market Share by Cell Line Generation Revenue (CR5) & (2017-2022)
  • Table 22. Key Players Headquarters and Area Served
  • Table 23. Key Players Cell Line Generation Product Solution and Service
  • Table 24. Established Date of Cell Line Generation Manufacturer
  • Table 25. Global Cell Line Generation Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Cell Line Generation Revenue Market Share by Type (2017-2022)
  • Table 27. Global Cell Line Generation Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Cell Line Generation Revenue Market Share by Type (2023-2028)
  • Table 29. Global Cell Line Generation Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Cell Line Generation Revenue Market Share by Application (2017-2022)
  • Table 31. Global Cell Line Generation Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Cell Line Generation Revenue Market Share by Application (2023-2028)
  • Table 33. North America Cell Line Generation Market Size by Country (2017-2022) & (US$ Million)
  • Table 34. North America Cell Line Generation Market Size by Country (2023-2028) & (US$ Million)
  • Table 35. Europe Cell Line Generation Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. Europe Cell Line Generation Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Asia-Pacific Cell Line Generation Market Size by Region (2017-2022) & (US$ Million)
  • Table 38. Asia-Pacific Cell Line Generation Market Size by Region (2023-2028) & (US$ Million)
  • Table 39. Latin America Cell Line Generation Market Size by Country (2017-2022) & (US$ Million)
  • Table 40. Latin America Cell Line Generation Market Size by Country (2023-2028) & (US$ Million)
  • Table 41. Middle East & Africa Cell Line Generation Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Middle East & Africa Cell Line Generation Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Boehringer Ingelheim BioXcellence Company Details
  • Table 44. Boehringer Ingelheim BioXcellence Business Overview
  • Table 45. Boehringer Ingelheim BioXcellence Cell Line Generation Product
  • Table 46. Boehringer Ingelheim BioXcellence Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 47. Lonza Group AG Company Details
  • Table 48. Lonza Group AG Business Overview
  • Table 49. Lonza Group AG Cell Line Generation Product
  • Table 50. Lonza Group AG Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 51. WuXi Biologics Company Details
  • Table 52. WuXi Biologics Business Overview
  • Table 53. WuXi Biologics Cell Line Generation Product
  • Table 54. WuXi Biologics Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 55. WuXi Biologics Recent Development
  • Table 56. Thermo Fisher Scientific Company Details
  • Table 57. Thermo Fisher Scientific Business Overview
  • Table 58. Thermo Fisher Scientific Cell Line Generation Product
  • Table 59. Thermo Fisher Scientific Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 60. Sartorious AG Company Details
  • Table 61. Sartorious AG Business Overview
  • Table 62. Sartorious AG Cell Line Generation Product
  • Table 63. Sartorious AG Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 64. Sartorious AG Recent Development
  • Table 65. Merck KGaA Company Details
  • Table 66. Merck KGaA Business Overview
  • Table 67. Merck KGaA Cell Line Generation Product
  • Table 68. Merck KGaA Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 69. Merck KGaA Recent Development
  • Table 70. Catalent Company Details
  • Table 71. Catalent Business Overview
  • Table 72. Catalent Cell Line Generation Product
  • Table 73. Catalent Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 74. Samsung Biologics Company Details
  • Table 75. Samsung Biologics Business Overview
  • Table 76. Samsung Biologics Cell Line Generation Product
  • Table 77. Samsung Biologics Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 78. FUJIFILM Diosynth Biotechnologies Company Details
  • Table 79. FUJIFILM Diosynth Biotechnologies Business Overview
  • Table 80. FUJIFILM Diosynth Biotechnologies Cell Line Generation Product
  • Table 81. FUJIFILM Diosynth Biotechnologies Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 82. Porton Biologics Company Details
  • Table 83. Porton Biologics Business Overview
  • Table 84. Porton Biologics Cell Line Generation Product
  • Table 85. Porton Biologics Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 86. Chempartner Pharmatech Company Details
  • Table 87. Chempartner Pharmatech Business Overview
  • Table 88. Chempartner Pharmatech Cell Line Generation Product
  • Table 89. Chempartner Pharmatech Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 90. Rentschler Biopharma Company Details
  • Table 91. Rentschler Biopharma Business Overview
  • Table 92. Rentschler Biopharma Cell Line Generation Product
  • Table 93. Rentschler Biopharma Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 94. ProBioGen Company Details
  • Table 95. ProBioGen Business Overview
  • Table 96. ProBioGen Cell Line Generation Product
  • Table 97. ProBioGen Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 98. AGC Biologics Company Details
  • Table 99. AGC Biologics Business Overview
  • Table 100. AGC Biologics Cell Line Generation Product
  • Table 101. AGC Biologics Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 102. OPM Biosciences Company Details
  • Table 103. OPM Biosciences Business Overview
  • Table 104. OPM Biosciences Cell Line Generation Product
  • Table 105. OPM Biosciences Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 106. Charles River Laboratories Company Details
  • Table 107. Charles River Laboratories Business Overview
  • Table 108. Charles River Laboratories Cell Line Generation Product
  • Table 109. Charles River Laboratories Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 110. Mycenax Biotech Company Details
  • Table 111. Mycenax Biotech Business Overview
  • Table 112. Mycenax Biotech Cell Line Generation Product
  • Table 113. Mycenax Biotech Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 114. JOINN Lab Company Details
  • Table 115. JOINN Lab Business Overview
  • Table 116. JOINN Lab Cell Line Generation Product
  • Table 117. JOINN Lab Revenue in Cell Line Generation Business (2017-2022) & (US$ Million)
  • Table 118. Research Programs/Design for This Report
  • Table 119. Key Data Information from Secondary Sources
  • Table 120. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Cell Line Generation Market Share by Type: 2021 VS 2028
  • Figure 2. Global Cell Line Generation Market Share by Application: 2021 VS 2028
  • Figure 3. Cell Line Generation Report Years Considered
  • Figure 4. Global Cell Line Generation Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 5. Global Cell Line Generation Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 6. Global Cell Line Generation Market Share by Region: 2021 VS 2028
  • Figure 7. Global Cell Line Generation Market Share by Players in 2021
  • Figure 8. North America Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 9. North America Cell Line Generation Market Share by Country (2017-2028)
  • Figure 10. United States Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 11. Canada Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 12. Europe Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 13. Europe Cell Line Generation Market Share by Country (2017-2028)
  • Figure 14. Germany Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 15. France Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 16. U.K. Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 17. Italy Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 18. Russia Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 19. Nordic Countries Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Asia-Pacific Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Asia-Pacific Cell Line Generation Market Share by Region (2017-2028)
  • Figure 22. China Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Japan Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. South Korea Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. Southeast Asia Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. India Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. Australia Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Latin America Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Latin America Cell Line Generation Market Share by Country (2017-2028)
  • Figure 30. Mexico Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Brazil Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Middle East & Africa Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Middle East & Africa Cell Line Generation Market Share by Country (2017-2028)
  • Figure 34. Turkey Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Saudi Arabia Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. UAE Cell Line Generation Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Bottom-up and Top-down Approaches for This Report
  • Figure 38. Data Triangulation
  • Figure 39. Key Executives Interviewed